Publications by authors named "Marwa Hakimi"

Article Synopsis
  • Psoriasis affects about 3% of the US population and is linked to various sleep disturbances, which can increase risks of cardiovascular issues, metabolic disorders, and depression.
  • The study analyzed data from the National Health and Nutrition Examination Survey to investigate the relationship between psoriasis and sleep problems, controlling for demographics and health history.
  • Findings indicate that psoriasis is strongly related to sleep issues but not sleep duration, highlighting the importance of evaluating sleep quality for better management of psoriasis and its complications.
View Article and Find Full Text PDF

Background: The risk of developing cutaneous T cell lymphoma (CTCL) in patients using psoriasis biologics has not been well characterized. The goals of this review were to investigate the incidence of CTCL in patients with psoriasis receiving biologic therapy in clinical trials and psoriasis registries, and to review cases of CTCL and biologic use reported in scientific publications.

Methods: The US National Library of Medicine clinical trials database (clinicaltrials.

View Article and Find Full Text PDF

Prior studies have found associations between atopic dermatitis (AD) and comorbidities, including depression, obesity, asthma, and allergic rhinitis. Although observational studies often cannot establish robust causality between potential risk factors and AD, Mendelian randomization minimizes confounding when exploring causality by relying on random allelic assortment at birth. In this study, we systematically reviewed 30 Mendelian randomization studies in AD.

View Article and Find Full Text PDF

Background: Poor sleep quality occurs in patients with psoriasis at rates nearly twice that of the general population. Chronic sleep impairment is an independent risk factor for the development of cardiovascular disease. Here, we examine the association between sleep quantity and history of myocardial infarction in patients with psoriasis.

View Article and Find Full Text PDF

Introduction: In-person dermatology clinical research studies often face recruitment and participation challenges due to travel-, time-, and cost-associated barriers. Studies incorporating virtual/asynchronous formats can potentially enhance research subject participation and satisfaction, but few mobile health tools are available to enable remote study conduct. We developed SkinTracker, a patient-facing mobile app and researcher-facing web platform, that enables longitudinal collection of skin photos, patient reported outcomes, and biometric health and environmental data.

View Article and Find Full Text PDF

Guselkumab is an anti-interleukin-23 monoclonal antibody that is approved for plaque psoriasis and psoriatic arthritis. We present a case of a 28-year-old female patient with acute onset of guttate psoriasis after a blistering sunburn. She had no personal or family history of psoriasis or chronic inflammatory skin disease.

View Article and Find Full Text PDF

Background: Psoriasis patients with poor therapeutic response to multiple biologic agents are not well-characterized.

Objective: To describe the characteristics associated with development of multiple biologic failure (MBF) versus good clinical response (GR) to the first biologic.

Methods: This prospective cohort analysis evaluated patients in the multicenter CorEvitas Psoriasis Registry who initiated their first biologic between 2015 and 2020 and were followed for ≥24 months.

View Article and Find Full Text PDF

Biologic therapies have been increasingly developed and used for the treatment of severe inflammatory diseases. However, the safety and efficacy profile of biologic drugs in patients with HIV is not well established as this patient population is historically excluded from clinical trials. We review the available evidence of biologic use in people with HIV.

View Article and Find Full Text PDF

Psoriasis vulgaris is a systemic, chronic inflammatory disease affecting 2-3% of the population. Recent advances in the understanding of the pathophysiology of psoriatic disease have facilitated the development of novel therapeutic options with improved safety and efficacy. This article is coauthored by a patient with a lifelong history of psoriasis who experienced multiple treatment failures.

View Article and Find Full Text PDF

Psoriasis (PSO) and psoriatic arthritis (PSA) are inflammatory diseases with complex genetic and environmental contributions. Although studies have identified environmental and clinical associations with PSO/PSA, causality is difficult to establish. Mendelian randomization (MR) employs the random assortment of genetic alleles at birth to evaluate the causal impact of exposures.

View Article and Find Full Text PDF

Background: This review's goals were to investigate apremilast's efficacy versus placebo in palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP), and apremilast's efficacy versus methotrexate in PP.

Methods: A literature search was conducted in PubMed, clinicaltrials.gov, and Embase in July 2022.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated patients with psoriasis (PsO) to see what factors lead them to use multiple biologic treatments compared to those using just one.
  • - Researchers analyzed data from 222 patients at UCSF, focusing on various demographics, clinical features, and co-morbidities that influence treatment choices, finding significant associations like duration of PsO and type of psoriasis.
  • - The results highlight the need for further research to improve treatment strategies for psoriasis, aiming for a more personalized medicine approach based on these identified factors.
View Article and Find Full Text PDF

Background: Hidradenitis suppurativa (HS) is an inflammatory skin disorder characterized by recurring painful and suppurating lesions, with the disease disproportionately affecting black populations in the United States. Ethnoracial representation in clinical trials is vital to ensuring results are generalizable. The purpose of this study is to examine whether ethnic or racial disparities exist in HS clinical trials.

View Article and Find Full Text PDF

Chronic inflammatory skin disorders are known to affect sleep quality; however, the relationship between hidradenitis suppurativa (HS) and sleep is not well understood. We performed a systematic review of HS and sleep disorders and sleep quality in HS patients. We identified seven studies comprising 343,870 subjects.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis (PSO) and psoriatic arthritis (PSA) are complex inflammatory diseases characterized by immune cell dysfunction, making early diagnosis and effective treatment challenging.
  • Single-cell RNA sequencing (scRNA-seq) has advanced our understanding by revealing distinct immune cell profiles and their interactions involved in PSO/PSA pathogenesis.
  • Analysis of recent studies suggests that while a small subset of immune cells can significantly influence disease outcomes, traditionally overlooked cell types also contribute, emphasizing the dynamic nature of immune responses and the potential for machine learning to enhance early diagnosis.
View Article and Find Full Text PDF

Psoriasis is a chronic, recurrent inflammatory skin condition in which flares are commonly associated with stress. One important non-pharmacological method for managing stress in patients with psoriasis is mindfulness and/or meditation. The objective of this review is to provide an update on research studies investigating the role of mindfulness and meditation in treating psoriasis symptoms, severity, and quality of life.

View Article and Find Full Text PDF

Introduction: Halobetasol propionate foam has been established as an efficacious and easy-to-use topical treatment for adults with plaque psoriasis. Its recent approval in the United States expanded its use for adolescents from ages 12 to 17 years old.

Areas Covered: We briefly summarize the chemistry of halobetasol and review clinical trials involving halobetasol propionate 0.

View Article and Find Full Text PDF

Psoriasis is a prevalent inflammatory skin disorder that is associated with a number of comorbidities including cardiovascular disease and metabolic syndrome. Exercise can influence the outcomes of chronic inflammatory diseases, and the presence of these diseases can also influence physical activity in afflicted patients. We reviewed the available literature published on exercise in psoriasis patients and aimed to explore physical activity levels, barriers to exercise, physical fitness, exercise as a prevention strategy as well as a treatment modality.

View Article and Find Full Text PDF